Wikidata

(Q84310525)

English

Ofatumumab, a human anti-CD20 monoclonal antibody, for treatment of rheumatoid arthritis with an inadequate response to one or more disease-modifying antirheumatic drugs: results of a randomized, double-blind, placebo-controlled, phase I/II study

scientific article published on 01 August 2010

In more languages

Statements

title
Ofatumumab, a human anti-CD20 monoclonal antibody, for treatment of rheumatoid arthritis with an inadequate response to one or more disease-modifying antirheumatic drugs: results of a randomized, double-blind, placebo-controlled, phase I/II study (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
20506254
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20506254%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 February 2020
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q84310525&oldid=1509255360"